Sustained measles transmission across multiple U.S. outbreaks continues to drive elevated case counts, with the CDC reporting 2,777 confirmed infections as of August 20, 2026—the highest annual total since 1991. This surge stems primarily from declining MMR vaccination coverage, now at 92.4% among kindergartners, leaving 94% of cases among unvaccinated or unknown-status individuals and fueling 36 outbreaks in 47 jurisdictions. Recent weekly increments reached 211 cases, concentrated in Pennsylvania and Ohio hotspots, while two measles-associated deaths were confirmed in unvaccinated Pennsylvania residents on August 25. With resolution on August 31 dependent on the CDC's official counter, the next surveillance update and any lag-reported cases from active clusters represent the key variables that could determine final tallies relative to market thresholds.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Casos de sarampión en EE. UU. antes del 31 de agosto?
¿Casos de sarampión en EE. UU. antes del 31 de agosto?
NUEVO
31 ago 2026
2800+
99%
2825+
96%
2850+
92%
2900+
66%
2950+
26%
$3,823 Vol.
2800+
$1,075 Vol.
99%
2825+
$560 Vol.
96%
2850+
$2,138 Vol.
92%
2900+
$0 Vol.
66%
2950+
$50 Vol.
26%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission across multiple U.S. outbreaks continues to drive elevated case counts, with the CDC reporting 2,777 confirmed infections as of August 20, 2026—the highest annual total since 1991. This surge stems primarily from declining MMR vaccination coverage, now at 92.4% among kindergartners, leaving 94% of cases among unvaccinated or unknown-status individuals and fueling 36 outbreaks in 47 jurisdictions. Recent weekly increments reached 211 cases, concentrated in Pennsylvania and Ohio hotspots, while two measles-associated deaths were confirmed in unvaccinated Pennsylvania residents on August 25. With resolution on August 31 dependent on the CDC's official counter, the next surveillance update and any lag-reported cases from active clusters represent the key variables that could determine final tallies relative to market thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Aug 24, 2026, 10:08 AM ET
Volumen
$3,823Fecha de finalización
31 ago 2026Mercado abierto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission across multiple U.S. outbreaks continues to drive elevated case counts, with the CDC reporting 2,777 confirmed infections as of August 20, 2026—the highest annual total since 1991. This surge stems primarily from declining MMR vaccination coverage, now at 92.4% among kindergartners, leaving 94% of cases among unvaccinated or unknown-status individuals and fueling 36 outbreaks in 47 jurisdictions. Recent weekly increments reached 211 cases, concentrated in Pennsylvania and Ohio hotspots, while two measles-associated deaths were confirmed in unvaccinated Pennsylvania residents on August 25. With resolution on August 31 dependent on the CDC's official counter, the next surveillance update and any lag-reported cases from active clusters represent the key variables that could determine final tallies relative to market thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$3,823Fecha de finalización
31 ago 2026Mercado abierto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...Sustained measles transmission across multiple U.S. outbreaks continues to drive elevated case counts, with the CDC reporting 2,777 confirmed infections as of August 20, 2026—the highest annual total since 1991. This surge stems primarily from declining MMR vaccination coverage, now at 92.4% among kindergartners, leaving 94% of cases among unvaccinated or unknown-status individuals and fueling 36 outbreaks in 47 jurisdictions. Recent weekly increments reached 211 cases, concentrated in Pennsylvania and Ohio hotspots, while two measles-associated deaths were confirmed in unvaccinated Pennsylvania residents on August 25. With resolution on August 31 dependent on the CDC's official counter, the next surveillance update and any lag-reported cases from active clusters represent the key variables that could determine final tallies relative to market thresholds.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes